SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-002944
Filing Date
2018-06-07
Accepted
2018-06-07 17:04:01
Documents
40
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bkit_10q.htm 10-Q 144950
2 CERTIFICATION bkit_ex311.htm EX-31.1 8906
3 CERTIFICATION bkit_ex312.htm EX-31.2 8767
4 CERTIFICATION bkit_ex321.htm EX-32.1 3494
11 bkit_10qimg1.jpg GRAPHIC 4453
  Complete submission text file 0001477932-18-002944.txt   984989

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bkit-20171130.xml EX-101.INS 103244
6 XBRL TAXONOMY EXTENSION SCHEMA bkit-20171130.xsd EX-101.SCH 17108
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bkit-20171130_cal.xml EX-101.CAL 20796
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkit-20171130_def.xml EX-101.DEF 26044
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkit-20171130_lab.xml EX-101.LAB 92565
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkit-20171130_pre.xml EX-101.PRE 74674
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

IRS No.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55022 | Film No.: 18887200
SIC: 7200 Services-Personal Services
Assistant Director 11